CIK 0001720580 · Non-accelerated filer<br>Smaller reporting company
Adicet Bio, Inc.
Sign in to watch- Ticker
- ACET
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 26
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813305277
- Phone
- 617-482-2333
- Business address
- 131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
- Former names
- resTORbio, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-24 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +1,116,903 | 1,116,903 | ||
| 2023-10-12 | Aftab Blake Chief Scientific Officer | Shares withheld for taxes | −7,933 | $1.35 | $11K | 46,376 |
| 2023-10-02 | Galimi Francesco SVP & Chief Medical Officer | Shares withheld for taxes | −8,093 | $1.37 | $11K | 80,458 |
| 2023-10-02 | Healey Don Chief Technology Officer | Shares withheld for taxes | −9,069 | $1.37 | $12K | 57,499 |
| 2023-10-02 | Harvey Brian Nicholas Chief Financial Officer | Shares withheld for taxes | −7,096 | $1.37 | $10K | 77,820 |
| 2023-10-02 | Schor Chen President & CEO | Purchase | +5,500 | $1.33 | $7K | 43,469 |
| 2023-10-02 | Schor Chen President & CEO | Shares withheld for taxes | −23,208 | $1.37 | $32K | 153,761 |
| 2023-09-29 | Schor Chen President & CEO | Sale | −5,500 | $1.36 | $7K | 176,969 |
| 2023-09-28 | Schor Chen President & CEO | Sale | −5,500 | $1.42 | $8K | 37,969 |
| 2023-09-28 | Schor Chen President & CEO | Purchase | +5,500 | $1.42 | $8K | 182,469 |
| 2023-08-14 | Schor Chen President & CEO | Returned to the company · Stock Option (Right to Buy) | −36,857 | 0 | ||
| 2023-08-14 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +36,857 | 36,857 | ||
| 2023-08-14 | Schor Chen President & CEO | Returned to the company · Stock Option (Right to Buy) | −872,111 | 0 | ||
| 2023-08-14 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +872,111 | 872,111 | ||
| 2023-08-14 | Schor Chen President & CEO | Returned to the company · Stock Option (Right to Buy) | −240,000 | 0 | ||
| 2023-08-14 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +240,000 | 240,000 | ||
| 2023-08-14 | Schor Chen President & CEO | Returned to the company · Stock Option (Right to Buy) | −421,600 | 0 | ||
| 2023-08-14 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +421,600 | 421,600 | ||
| 2023-08-14 | Schor Chen President & CEO | Returned to the company · Stock Option (Right to Buy) | −295,000 | 0 | ||
| 2023-08-14 | Schor Chen President & CEO | Grant or award · Stock Option (Right to Buy) | +295,000 | 295,000 |
Page 8 of 15 · 298 trades